10-Q: Vireo Growth Inc. Reports Q3 2024 Results, Revenue Up Slightly Amidst Strategic Shifts

Sentiment:

Quarterly Report 13 November 2024 4:20 PM

Vireo Growth Inc. saw a modest revenue increase in Q3 2024, driven by growth in Maryland, while navigating ongoing strategic changes and legal challenges.

Delay expectedThe company failed to complete the New York Disposition by January 1, 2024, resulting in an Event of Default under the credit agreement.

Capital raiseThe company is considering capital raises as part of its plan to mitigate substantial doubt about its ability to continue as a going concern.The company issued 12.5 million subordinate voting shares to lenders in consideration for the credit facility amendment.The company entered into a Joinder and Tenth Amendment to the Credit Facility, which provides a financing commitment of up to $10.0 million in aggregate principal amount of convertible notes.

Worse than expectedThe company's net loss and the uncertainty surrounding its ability to continue as a going concern indicate worse than expected results.

Summary

Vireo Growth Inc. reported a 2% increase in revenue for the three months ended September 30, 2024, reaching $25.16 million, compared to $24.67 million in the same period last year.
The company's retail revenue decreased slightly by 2%, while wholesale revenue increased by 20% in the same period.
For the nine months ended September 30, 2024, total revenue was $74.36 million, a 16% increase compared to $63.96 million in the same period of 2023.
The company experienced a net loss of $4.92 million for the quarter and $12.3 million for the nine-month period.
The company is actively working on a plan to mitigate substantial doubt about its ability to continue as a going concern, which may include asset sales, debt restructuring, and capital raises.
The company is seeking $860.9 million in damages from Verano due to a breach of contract.

Sentiment

Score: 3

Explanation: The document presents a mixed picture with some positive revenue growth but significant concerns about profitability, legal challenges, and the company's ability to continue as a going concern. The overall sentiment is negative due to the financial uncertainties and strategic shifts.

Positives

The company experienced a 2% increase in revenue for the quarter and a 16% increase for the nine-month period.
Wholesale revenue saw a significant increase of 20% in Q3 2024.
The company has extended its credit facility maturity date to January 29, 2027, providing more financial flexibility.
The company has successfully converted all outstanding convertible notes into subordinate voting shares, simplifying its capital structure.
The company is actively pursuing legal action against Verano for breach of contract, seeking substantial damages.

Negatives

The company reported a net loss of $4.92 million for the quarter and $12.3 million for the nine-month period.
Retail revenue decreased slightly by 2% in Q3 2024.
The company's ability to continue as a going concern is in doubt due to the termination of the Verano agreement.
The company is facing sales pricing compression in Minnesota and Maryland.
The company has identified assets in New York, Nevada, and Massachusetts as held for sale, indicating potential restructuring.

Risks

The termination of the Verano agreement raises substantial doubt about the company's ability to continue as a going concern.
The company's future profitability is dependent on its ability to implement a plan that may include asset sales, debt restructuring, and capital raises.
The company is facing sales pricing compression in key markets, which could impact future revenue and profitability.
The company is involved in ongoing litigation with Verano, the outcome of which is uncertain.
The company's access to financing is always uncertain, and there is no assurance of continued access to significant equity or debt financing.

Future Outlook

The company's future is uncertain due to the termination of the Verano agreement, and its ability to continue as a going concern is dependent on implementing a plan that may include asset sales, debt restructuring, and capital raises. The company expects gradual price compression as markets mature, which could place downward pressure on retail and wholesale gross margins.

Management Comments

Company management is working with the company's lenders, counsel, and other applicable parties to implement a plan to effectively mitigate the conditions giving rise to substantial doubt about the company's ability to continue as a going concern.
The company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations.

Industry Context

The cannabis industry is facing increasing competition and regulatory changes, which are impacting pricing and profitability. Vireo Growth is navigating these challenges while also dealing with company-specific issues such as the terminated Verano agreement and the need for restructuring. The company's performance is reflective of the broader industry trends of increasing competition and price compression.

Comparison to Industry Standards

Compared to other multi-state cannabis operators, Vireo's revenue growth of 2% in Q3 is relatively modest, while some competitors have seen double-digit growth in mature markets.
The company's gross margin of 49% is within the range of industry averages, but the company is facing price compression which may impact future margins.
The company's net loss of $4.92 million for the quarter is significant and highlights the challenges of achieving profitability in the current market environment.
The company's legal battle with Verano is a unique situation that is not typical of the industry, and the outcome could have a significant impact on the company's future.
The company's need to restructure and potentially sell assets is a sign of financial distress, which is not uncommon in the cannabis industry, but it is a concern for investors.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Chief Executive Officer, Interim Chief Financial Officer and Director	Joshua Rosen	Amber Shimpa (Chief Executive Officer), Joseph Duxbury (Interim Chief Financial Officer)	October 10, 2024	Resignation

Legal Proceedings

The company is involved in ongoing litigation with Verano, seeking $860.9 million in damages for breach of contract.
The company is involved in various regulatory issues, claims and lawsuits arising in the ordinary course of business.

Stakeholder Impact

Shareholders face significant uncertainty due to the company's financial challenges and the ongoing legal battle with Verano.
Employees may be affected by potential restructuring and asset sales.
Customers may experience changes in product availability and pricing due to the company's strategic shifts.
Suppliers and creditors face increased risk due to the company's financial instability.

Next Steps

The company will continue to work on its plan to mitigate substantial doubt about its ability to continue as a going concern, which may include asset sales, debt restructuring, and capital raises.
The company will continue to pursue legal action against Verano.
The company will continue to work on the disposition of its New York operations.
The company will focus on improving its financial performance and operational efficiency.

Key Dates

Date	Description
November 23, 2004	Vireo Growth Inc. was incorporated under the Alberta Business Corporations Act.
March 25, 2021	The company entered into a credit agreement for a senior secured delayed draw term loan.
January 31, 2022	The company entered into an Arrangement Agreement with Verano, which was later terminated.
October 21, 2022	Vireo Growth commenced legal action against Verano.
April 28, 2023	The company closed on a new convertible debt facility.
July 1, 2023	Adult-use sales commenced in Maryland.
July 8, 2024	The company changed its name to Vireo Growth Inc. and its ticker symbol on the CSE to VREO and its ticker symbol on the OTCQX to VREOF.
May 2, 2024	The company filed an application with the Supreme Court of British Columbia for summary determination against Verano.
July 31, 2024	The company executed a ninth amendment to its credit facility and all outstanding convertible notes were converted into subordinate voting shares.
September 30, 2024	End of the reporting period for the quarterly results.
October 9, 2024	The company and Grown Rogue mutually agreed to terminate their Consulting Agreement.
October 10, 2024	Joshua Rosen, Chief Executive Officer, Interim Chief Financial Officer and Director of the Company resigned from all of his positions with the Company.
November 1, 2024	The company entered into a Joinder and Tenth Amendment to the Credit Facility.
November 11, 2024	Date of share count disclosure.
November 13, 2024	Date of the filing of the quarterly report.

Keywords

cannabis, revenue, net loss, EBITDA, credit facility, convertible debt, asset sales, legal proceedings, going concern, wholesale, retail

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.